Vital Signs Monitoring Devices Global Market 2022: Sector to Reach $7.4 Billion by 2027 at a CAGR of 6.75% – ResearchAndMarkets.com

The “Vital Signs Monitoring Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering.

The global vital signs monitoring devices market size reached US$ 5.0 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 7.4 Billion by 2027, exhibiting a CAGR of 6.75% during 2021-2027.

Companies Mentioned

  • A&D Company Ltd.
  • Contec Medical Systems Co. Ltd.
  • GE Healthcare
  • Koninklijke Philips N.V.
  • Masimo
  • Medtronic
  • Nihon Kohden Corporation
  • Nonin Medical Inc.
  • Omron Healthcare Inc.
  • Smiths Group Plc

Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Vital signs monitoring devices refer to various medical equipment used for monitoring a patient’s vital signs. This includes blood pressure monitoring devices, pulse oximeters and temperature monitoring devices that are used for observing various vital signs, such as blood pressure, body temperature, pulse rate and respiratory rate.

These devices are portable, small-sized, reliable and can be set up in a medical setting, residential complexes and at the site of a medical emergency. They can also be used for monitoring activity and fitness levels for self-health tracking and early diagnosis of medical ailments.

The increasing prevalence of chronic and lifestyle-associated medical ailments across the globe is one of the key factors driving the growth of the market.

Furthermore, growing geriatric population and increasing awareness regarding home monitoring devices are also providing a boost to the market growth.

As at-home vital signs monitoring devices are cost-effective, easy-to-use and can measure various physiological parameters of the body using multi-parameter patient monitors, it is contributing to their rising demand. Apart from this, the onset of COVID-19 (coronavirus disease) has led to a significant increase in the demand of these devices to determine the patient’s health status, provide them with appropriate care and predict recovery.

Additionally, various technological advancements, such as the integration of health monitoring devices with bluetooth, sensors and micro-electric technologies, are also creating a positive outlook for the market. Other factors, including improvements in the healthcare infrastructure and the increasing adoption of wearable healthcare devices, are expected to drive the market further.

Key Questions Answered in This Report

1. What was the size of the global vital signs monitoring devices market in 2021?

2. What is the expected growth rate of the global vital signs monitoring devices market during 2022-2027?

3. What are the key factors driving the global vital signs monitoring devices market?

4. What has been the impact of COVID-19 on the global vital signs monitoring devices market?

5. What is the breakup of the global vital signs monitoring devices market based on the product type?

6. What is the breakup of the global vital signs monitoring devices market based on the end-user?

7. What are the key regions in the global vital signs monitoring devices market?

8. Who are the key players/companies in the global vital signs monitoring devices market?

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

4.1 Overview

4.2 Key Industry Trends

5 Global Vital Signs Monitoring Devices Market

5.1 Market Overview

5.2 Market Performance

5.3 Impact of COVID-19

5.4 Market Forecast

6 Market Breakup by Product Type

6.1 BP Monitoring Devices

6.1.1 Market Trends

6.1.2 Major Types

6.1.2.1 Aneroid BP Monitors

6.1.2.2 Automated BP Monitors

6.1.3 Market Forecast

6.2 Pulse-Oximeters

6.2.1 Market Trends

6.2.2 Major Types

6.2.2.1 Tabletop/Bedside Pulse-Oximeters

6.2.2.2 Fingertip

6.2.2.3 Handheld

6.2.2.4 Wrist Worn

6.2.2.5 Pediatric Pulse-Oximeters

6.2.3 Market Forecast

6.3 Temperature Monitoring Devices

6.3.1 Market Trends

6.3.2 Major Types

6.3.2.1 Mercury-Filled Thermometers

6.3.2.2 Digital Thermometers

6.3.2.3 Infrared Thermometers

6.3.2.4 Temperature Strips

6.3.3 Market Forecast

6.4 Others

6.4.1 Market Trends

6.4.2 Market Forecast

7 Market Breakup by End-User

7.1 Hospitals and Clinics

7.1.1 Market Trends

7.1.2 Market Forecast

7.2 Ambulatory Surgery Centers (ASCs)

7.2.1 Market Trends

7.2.2 Market Forecast

7.3 Home Care

7.3.1 Market Trends

7.3.2 Market Forecast

7.4 Others

7.4.1 Market Trends

7.4.2 Market Forecast

8 Market Breakup by Region

9 SWOT Analysis

10 Value Chain Analysis

11 Porters Five Forces Analysis

12 Price Analysis

13 Competitive Landscape

13.1 Market Structure

13.2 Key Players

13.3 Profiles of Key Players

For more information about this report visit https://www.researchandmarkets.com/r/kepduo-signs?w=4

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”